Understanding Muscle Weakness in Limb Girdle Muscular Dystrophy
Chaperone Dysfunction in Myopathy: Connecting Yeast Genetics with Mouse Models
This project explores how changes in certain proteins cause muscle weakness in a specific type of muscular dystrophy, hoping to find new ways to help patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Washington University NIH-funded |
| Lab location | 1 site (Saint Louis, United States) |
| Project ID | NIH-11137060 on NIH RePORTER |
What this research studies
Our muscles rely on special proteins called chaperones to stay healthy. When these chaperones don't work correctly due to genetic changes, it can lead to conditions like Limb Girdle Muscular Dystrophy (LGMDD1), causing muscle weakness. This project looks at specific changes in a chaperone protein called DNAJB6 and how they disrupt muscle function. We are using both human cells and mouse models to understand these changes and test if we can correct them by adjusting how DNAJB6 interacts with another protein, HSP70. The goal is to uncover new treatment approaches that could improve muscle health for those with LGMDD1.
Who could benefit from this research
Good fit: This foundational research focuses on understanding the genetic causes of Limb Girdle Muscular Dystrophy type D1, and future clinical applications would target individuals diagnosed with this specific condition.
Not a fit: Patients with muscular dystrophies not linked to DNAJB6 chaperone dysfunction in LGMDD1 may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new treatment strategies that directly address the underlying protein issues in Limb Girdle Muscular Dystrophy type D1, potentially improving muscle function for patients.
How similar studies have performed: This project builds upon existing knowledge of heat shock proteins and their role in muscle diseases, with preliminary data suggesting promising therapeutic targets.
Where this research is happening
Saint Louis, United States
- Washington University — Saint Louis, United States (Active)
Researchers
- Principal investigator: True-Krob, Heather L — Washington University
- Study coordinator: True-Krob, Heather L
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.